Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT05200637
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT05200637
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT05200637. Randomized; no masking; primary purpose treatment. Start 2022-02-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Orsiro stent
- Intervention (Device)
- Xience stent
- Intervention (Device)
- Any drug-eluting stent
- Lead sponsor
- Chang Gung Memorial Hospital
Record details
- Record id
cardio:ct-nct05200637- Content hash
7e32be3d3ca0c21ed1573680fca0f3f1849966e97d5752ee207cc44160f18e1d